Zenith Drugs Limited (NSE:ZENITHDRUG)

India · Delayed Price · Currency is INR

47.85

+1.50 (3.24%)

Sep 11, 2026, 3:25 PM IST

Market Cap	820.57M -30.7%
Revenue (ttm)	1.71B +28.4%
Net Income	39.43M -44.9%
EPS	2.30 -44.9%
Shares Out	17.15M
PE Ratio	20.80
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,000
Open	46.50
Previous Close	46.35
Day's Range	46.50 - 47.85
52-Week Range	33.30 - 73.45
Beta	1.40
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Zenith Drugs

Zenith Drugs Limited, together with its subsidiaries, manufactures and trades in branded, generic, and OTC medicines. The company offers a range of pharmaceutical formulations, such as ORS powder, liquid orals, ointments, creams, gels, liquid externals, capsules, and tablets. Its products are indicated for allergology, general analytics, infections, genetics, endocrinology, and microbiology. The company operates in India, Costa Rica, Mauritius, Cambodia, Myanmar, Yemen, Sierra, Leone, Liberia, and Bhutan. Zenith Drugs Limited was incorporated i... [Read more]

Industry Medical - Pharmaceuticals

Sector Healthcare

Founded 1956

Employees 182

Stock Exchange National Stock Exchange of India

Ticker Symbol ZENITHDRUG

Full Company Profile

Financial Performance

In fiscal year 2026, Zenith Drugs's revenue was 1.71 billion, an increase of 28.43% compared to the previous year's 1.33 billion. Earnings were 39.43 million, a decrease of -44.94%.

Financial Statements